New drug LEO 158968 put to the test in healthy volunteers
NCT ID NCT05682352
First seen Apr 29, 2026 · Last updated May 22, 2026 · Updated 4 times
Summary
This early-stage study tested a new compound called LEO 158968 in 120 healthy adults aged 18 to 60. The goal was to see what side effects it might cause, how well it is tolerated, and how the body processes it. Participants received either the drug or a placebo, and researchers monitored their health closely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
LEO Pharma Investigational Site
Groningen, 9728, Netherlands
Conditions
Explore the condition pages connected to this study.